Table 1.
Demographics and clinical characteristics of the patients with Vogt-Koyanagi-Harada and long-standing disease
| Description | ||
|---|---|---|
| Number of patients (eyes) |
28 |
(51) |
| Age (years), mean (± 1SD) |
39.9 |
±13.0 |
| Gender, male (%) |
4 |
(14.3) |
| Race, n (%) | ||
| White |
12 |
(42.8) |
| Mestizo |
10 |
(35.7) |
| Black |
4 |
(14.3) |
| Asian/Oriental |
2 |
(7.1) |
| Revised Diagnostic Criteria category [14], n (%) | ||
| Complete |
7 |
(25.0) |
| Incomplete |
14 |
(50.0) |
| Probable |
7 |
(25.0) |
| Clinical activity (SUN) [15], n (%) | ||
| Remission¶ |
11 |
(39.3) |
| Inactive§ |
5 |
(17.8) |
| Active |
12 |
(42.8) |
| Use of systemic medication, n (%) |
|
|
| Prednisone only |
5 |
(17.8) |
| Prednisone and immunosuppressant |
5 |
(17.8) |
| Immunosuppressants only |
3 |
(10.7) |
| None |
15 |
(53.6) |
| Disease duration (in months), median (range) | 91.5 | (9–348) |
¶Inactive disease for ≥3 months after discontinuing all treatments for eye disease.
§ Grade 0 cells.